PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc2013728.pdf
Reference55 articles.
1. Bader AG, Brown D, Winkler M (2011) The promise of microRNA replacement therapy. Cancer Res 70: 7027–7030.
2. Barton LF, Runnels HA, Schell TD, Cho Y, Gibbons R, Tevethia SS, Deepe Jr GS, Monaco JJ (2004) Immune defects in 28-kDa proteasome activator gamma-deficient mice. J Immunol 172: 3948–3954.
3. Cai Y, Xiong S, Zheng Y, Luo F, Jiang P, Chu Y (2011) Trichosanthin enhances anti-tumour immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM. Cell Mol Immunol 8: 359–367.
4. Cataldo VD, Gibbons DL, Perez-Soler R, Quintas-Cardama A (2011) Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N Engl J Med 364: 947–955.
5. Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM (2007) Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 26: 843–852.
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect;International Journal of Hematology;2024-07-02
2. ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway;Molecular Carcinogenesis;2024-06-18
3. Promoter A1312C mutation leads to microRNA-7 downregulation in human non-small cell lung cancer;Cellular Signalling;2024-05
4. Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer;Acta Pharmaceutica Sinica B;2023-10
5. Structure, Function, and Allosteric Regulation of the 20S Proteasome by the 11S/PA28 Family of Proteasome Activators;Biomolecules;2023-08-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3